Regenerative medicine studies not only cells, but also the signals they use to communicate with other tissues and their environment.
The term secretome is used to describe the collection of molecules released by cells, such as proteins, lipids, RNA, extracellular vesicles and other signaling components. Within this broader group, exosomes are among the best-known elements.
It is the collection of signals and products released by cells into their environment. Studying it helps us understand intercellular communication processes.
They are a type of extracellular vesicle that may participate in biological signaling processes between cells.
Because part of the current scientific interest focuses on how these signals may influence certain biological microenvironments.
Standardization, characterization, variability between products and the correlation between the product and the clinical effect.
The study of the secretome and exosomes is an active field. Biological mechanisms and research findings do not by themselves establish the safety or effectiveness of a commercial product. Each product and use require clinical evidence and review of applicable authorizations.
How a product is obtained, handled and characterized is relevant when interpreting its potential use within a clinical context.
Whether this type of approach may be considered depends on the clinical case, goals and professional assessment.
At CellNova, this topic is addressed as part of a comprehensive evaluation, rather than as a generalized promise.
Not exactly. The secretome is a broader concept. Exosomes are part of this collection of products and signals released by cells.
Because they represent a widely studied part of intercellular communication and have attracted interest in regenerative medicine and applied biology.
No. Origin, characterization, production processes and handling may vary, making product quality an important issue.
You can continue on our pages on Cell quality and Mesenchymal cells.
Understanding cell signaling also involves understanding the product, its quality and the patient’s clinical context.
Educational information. The availability and suitability of any intervention depend on an individual medical evaluation. Results may vary from patient to patient.Findings on cell signaling and extracellular vesicles do not by themselves validate a commercial product. Laboratory findings or results from one product should not be extrapolated to another to claim clinical safety or effectiveness.
The information on this page is educational and does not replace an individual medical evaluation. Evidence, risks and regulatory status vary by intervention, product and proposed use. Research on a biological mechanism does not by itself establish that a treatment is safe or effective. A cure, regeneration or specific clinical outcomes are not guaranteed. Decisions require review of the applicable evidence, risks, alternatives and informed consent.